Trials / Completed
CompletedNCT00219609
Assessment Of Safety Of UK-390,957
A Phase 2 Multi-Center, Open Label Long-Term Extension Trial To Assess The Safety Of Oral Uk-390,957 Administered As Required In Adult Men With Premature Ejaculation
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 1,058 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine whether UK-390,957 is a safe treatment for premature ejaculation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | UK-390,957 |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2006-03-01
- Completion
- 2006-03-01
- First posted
- 2005-09-22
- Last updated
- 2012-11-07
Locations
82 sites across 14 countries: United States, Australia, Austria, Canada, Czechia, France, Germany, Israel, Italy, Norway, Poland, Sweden, Turkey (Türkiye), United Kingdom
Source: ClinicalTrials.gov record NCT00219609. Inclusion in this directory is not an endorsement.